"Many patients are
finding relief by taking our products alone or in tandem with prescription
medications.ibsgroup.

Axcan's products are marketed by its own sales force in North America and
Europe. Actual results could differ
materially from those projected herein and depend on a number of factors
including but not limited to risks and uncertainties , which may include
acceptance and demand for new pharmaceutical products, the impact of
competitive products and pricing, new product development and launch,
reliance on key strategic alliances, availability of raw materials, the
regulatory environment, fluctuations in operating results and other risks
detailed from time to time in the Company's filings with the Securities
and Exchange Commission and under the Canadian Multijurisdictional
Disclosure System.

digestive cushion

M.

digestive cushion

org , there are many vocal advocates for Ganeden's
formulation of probiotics.G.

pad inflammatory

, a family physician affiliated with the Cleveland
Clinic and University Hospitals in Cleveland. For a free sample, call
800.

drain pad

"On our Web
site, http://www. Axcan markets a broad line of prescription products sold
for the treatment of symptoms in a number of gastrointestinal diseases and
disorders such as irritable bowel disorder, irritable bowel syndrome,
cholestatic liver diseases and complications related to cystic fibrosis.

eze constipation

Ganeden's patented strain of
Lactobacillus used in Digestive Advantage(TM) and other company products is
the culmination of that intensive research effort. The Company markets a broad line of prescription products
sold for the treatment of symptoms in a number of gastrointestinal diseases
and disorders such as inflammatory bowel disease, irritable bowel syndrome,
cholestatic liver diseases and complications related to cystic fibrosis. Its common shares are listed on the Toronto Stock Exchange under the
symbol "AXP" and on the NASDAQ National Market under the symbol "AXCA".

("Axcan" or the "Company") announced today the launch of CANASA 1000 mg,
the only FDA approved once -daily mesalamine suppository for the treatment of
ulcerative proctitis. Its common shares are listed on the Toronto Stock Exchange under the
symbol "AXP" and on the NASDAQ National Market under the symbol "AXCA".

deodorizer bowel

First Probiotic Clinically Proven to Benefit Both IBS and Crohn's Disease Patients Achieves High Conversion Rates Among Samplers of the Product

In one double-blind, placebo-controlled study of patients who suffer from
painful IBS, 57 percent of the participants noted a significant reduction in
abdominal pain and bloating after taking Ganeden's IBS treatment, Digestive
Advantage (TM), for eight weeks. Affecting as many as one in five
Americans, IBS can have a substantial impact on patients' lives and forces
many people with IBS to restrict their diets drastically to manage symptoms. "While it may not work for
everyone, I prefer my IBS patients first try this product before moving onto
more aggressive and expensive treatments.
with approximately 400,000 new cases every year.

prunes charcoal

ET. Axcan received a three-year marketing exclusivity for
the new dosage form under the non -patent exclusivity provisions of the Federal
Food, Drug and Cosmetic Act.

cushion establish

In fact, four out of five patients who were using prescription
medications were able to stop taking their standard medications ."
Probiotic, or "good bacterium" treatments for various inflammatory
conditions have been used for thousands of years. Verwiel, M.

drain smell

Dozens of
my patients take it regularly to level off their symptoms with great success,"
said Terrence Isakov, M.
Jeffrey Roberts, founder of the IBS Association has benefited from daily
use of probiotics to control his IBS symptoms for many years . He discovered
Ganeden's probiotics in 2004. Miguel Regueiro, Associate
Professor of Medicine and Co-Director of the Inflammatory Bowel Disease Center
at the University of Pittsburgh Medical Center.

odor pad

, will
present an overview of the Company at Merrill Lynch's Global Pharmaceutical,
Biotechnology and Medical Device Conference held in New York, NY.

drain beltless

CLEVELAND, Ganeden Biotech, a medical foods and
probiotics manufacturer, today announced the company has gathered initial
clinical data to support its Digestive Advantage(TM) treatment.
"While our treatments are not cures, they are a natural, clinically proven
way to control the symptoms of these two debilitating conditions," said Andy
Lefkowitz, chief executive officer of Ganeden Biotech.
Ganeden invested heavily in an R+D effort to analyze virtually every
strain of Lactobacillus, a lactic-acid producing bacteria that is known to
help maintain proper gastro-intestinal function. 28 - Axcan Pharma
Inc. In approximately 30% of patients with
ulcerative colitis, the illness begins as ulcerative proctitis where bowel
inflammation is limited to the rectum.

flatulence constipation

Both studies
demonstrate why thousands of people suffering from Irritable Bowel Syndrome
(IBS) and Crohn's disease are converting to its products as an alternative to
costly , aggressive prescription drugs that often have undesirable -- even
dangerous -- side effects.M.

This release contains forward-looking statements, which reflect the
Company's current expectations regarding future events.

pad bowel

In a second proof-of-concept clinical trial involving patients with
Crohn's disease, an extremely painful disease of the large intestine, patients
taking Digestive Advantage(TM) noted a 40 percent reduction in episodes of
diarrhea.ganedenbiotech.

drain deodorizer

IBS is a chronic condition of the
gastrointestinal tract that is characterized by erratic episodes of abdominal
pain , bloating, diarrhea, and constipation. "The use of probiotic supplements to manage IBS
is a recurring theme in current medical research," Roberts said.

Axcan is a leading specialty pharmaceutical company involved in the field
of gastroenterology. To the extent any
statements made in this release contain information that is not historical,
these statements are essentially forward looking and are often identified by
words such as "anticipate," "expect," "estimate," "intend," "project," "plan "
and "believe."
In the United States, the rectal mesalamine market is valued at
approximately U.

ABOUT ULCERATIVE PROCTITIS

Ulcerative proctitis is a subgroup of ulcerative colitis, one of the most
common inflammatory bowel diseases. To the extent any
statements made in this release contain information that is not
historical, these statements are essentially forward looking and are
often identified by words such as "anticipate," "expect," "estimate, "
"should," "project," "plan," and "believe." Forward-looking statements
are subject to risks and uncertainties.

smell molo

Axcan Launches CANASA 1000 mg in the U.S.

S.

"Safe Harbor" statement under the Private Securities Litigation Reform
--------------------------- -------------------------------------------
Act of 1995.

elevate heartburn

D. Using Digestive Advantage(TM) has the potential to allow many of them
to enjoy a more normal diet, including salads, pizza, and other foods , which
IBS patients routinely deny themselves. TSX SYMBOL (Toronto Stock Exchange): AXP
Nasdaq SYMBOL (Nasdaq National Market): AXCA

MONT SAINT-HILAIRE, Quebec, Feb. $82 million annually.
------------

This press release contains forward-looking statements , which reflect the
Company's current expectations regarding future events.

mattresses pad

If it does not work for a particular
patient, there is absolutely no risk of harm or side effects with Digestive
Advantage (TM).com .
A webcast of Axcan's presentation can also be accessed via the Company's
website at http://www." Forward-looking statements are subject to risks and
uncertainties, including the difficulty of predicting FDA and other regulatory
approvals, acceptance and demand for new pharmaceutical products, the impact
of competitive products and pricing, new product development and launch,
reliance on key strategic alliances, availability of raw materials, the
regulatory environment, fluctuations in operating results, the protection of
our intellectual property and other risks detailed from time to time in the
Company's filings with the Securities and Exchange Commission and the Canadian
securities regulatory authorities.
"The once-a-day CANASA 1000 mg suppository offers a new treatment option
for patients with ulcerative proctitis," said Dr.S.

heartburn bowel

However, despite repeated
attempts, modern drug makers have not been able to find the optimal bacterial
strain to provide the most benefit.

31 - Axcan Pharma
Inc. ("Axcan" or the "Company") today announced that on Tuesday, February 7,
2006 , president and chief executive officer, Frank A.D. According to IMS Health data
published in December 2004, approximately 56% of all U.
Axcan's products are marketed by its own sales force in North America and
Europe.

charcoal flatulence

456.

Axcan Pharma to present at Merrill Lynch Global Healthcare Conference

gastrointestinal
prescriptions for rectal mesalamine were written for CANASA 500 mg, making
Axcan's CANASA 500 mg the most prescribed brand of rectal mesalamine in the
U.

The name CANASA is a trademark of Axcan Pharma Inc.

pad elevate

"
A one month supply of Digestive Advantage(TM) costs approximately $10 and
is available at most large drug store chains. and its subsidiaries.

regularity molo

For many patients, Digestive Advantage(TM) is an
affordable, safe way to alleviate and free themselves from the worst symptoms
of IBS.0276 , or visit Ganeden's Web site at http://www. This
presentation will take place at 10:20 A.com.S.

ABOUT AXCAN PHARMA

Axcan is a leading specialty pharmaceutical company involved in the field
of gastroenterology.

inflammatory beltless

axcan.

regularity bowel

Ganeden is so confident in the
product that it gives away an eight-day sample so that patients can realize
the benefits of Digestive Advantage (TM) without cost. TSX SYMBOL (Toronto Stock Exchange): AXP
NASDAQ SYMBOL (NASDAQ National Market): AXCA

MONT SAINT-HILAIRE, QC, Jan.

"Safe Harbor" statement under the Private Securities Litigation Reform
Act of 1995.

drain mattresses

"
"I am very pleased with the results of Digestive Advantage(TM).

"The 1000 mg suppository is as
efficacious as the twice-a-day CANASA 500 mg suppository, but 1000 milligrams
once a day is easier for patients to use and should improve compliance.S. Currently, it is estimated that there
are approximately 1,000,000 cases of inflammatory bowel disease in the U.

eze mattresses

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)